Dr. Ali Taher
Professor of Medicine Hematology & Oncology
Associate Chair – Research
Department of Internal Medicine
American University of Beirut Medical Center
Dr. Ali Taher
Dr. Ali Taher is a Professor of Medicine at the Division of Hematology & Oncology, Department of Internal Medicine, at the “American University of Beirut Medical Center” (AUBMC) located in, Beirut, Lebanon. He is also the Vice Chair for Research at the Department and the Director of the “Fellowship Resident Research Program” (FRRP) at AUBMC.
In addition, Dr. Taher is an integral member of a team of consultants at the Thalassemia Department of the “Chronic Care Center” (CCC) located in Hazmieh, Lebanon where he has contributed to state of the art prevention and management programs for thalassemia patients in the country.
Most recently, Dr. Taher was recognized with the “International Leader in Thalassemia” award by the “Sultan Bin Khalifa International Thalassemia Awards” that has been always presented to a personality that has contributed significant work in Thalassemia and Hemoglobinopathies and has achieved a measurable impact in improving patients’ quality of life.
Dr. Taher was also granted the “Fellowship of the Royal College of Physicians” in appreciation of his dedication to advancing knowledge and research, as well as being awarded a “Doctor of Philosophy Degree” (PhD) from Leiden University Medical Center (LUMC) for his ground breaking work on thalassemia intermedia which unraveled morbidity behind the disease.
Dr. Taher is an adjunct Professor of Hematology & Medical Oncology at Emory School of Medicine, Atlanta, GA, USA and a Member of the “Alpha Omega Alpha Honor Medical Society”.
Dr. Taher is well known for his dedication and active role in research on the various hemoglobinopathies, especially the thalassemias, both nationally and internationally. Achieving better patient outcomes and quality of life remains at the heart of his work. Dr. Taher has over 450 articles published in leading peer-reviewed international journals. Dr. Taher was the principal investigator on key clinical trials evaluating the efficacy and safety of iron chelation therapy in regularly transfused and non-transfusion dependent thalassemias. Dr. Taher continues to evaluate new treatment strategies and chelators to help achieve optimal control of iron overload in these patient populations.
Dr. Taher has always set an example of how fruitful research partnerships can be, by participating in studies of large collaborative networks (“National Institutes of Health” (NIH), USA). In recognition of the quality of his research and his dedication to find new treatments to improve the thalassemic patients’ quality of life, Dr. Taher’s research has received numerous grants.
He has also shown leadership in creating local and regional scientific interest groups and associations that promote partnerships in science and dissemination of knowledge to both physicians and the community. Such partnerships within the Middle East and with Italy in particular were a success story which yielded data that reshaped our understanding of thalassemia intermedia (OPTIMAL Care and ORIENT Study). Such work had a major impact on establishing management guidelines by the “Thalassaemia International Federation” (TIF) for both regularly transfused and non-transfusion-dependent thalassemias, for which Dr. Taher served as an Editor.
Dr. Taher is an Associate Editor of the Journal “Hemoglobin” and a reviewer for the top ten hematology journals. Dr. Taher is a regular contributor to all major international scientific meetings in Hematology.
However, it has been well documented that Dr. Taher’s ultimate passion is mentoring and sharing his knowledge with the young generation of physician scientists…